Third Rock's Ambys hauls $140M for liver disease, inking Takeda deal ahead of launch
It won’t shock anyone that a new company has rolled off Third Rock’s startup conveyor belt (this VC firm is a machine at creating new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
